Sibel Kalyoncu
Izmir, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
VISTA as a Double-Edged immune checkpoint molecule in cancer and autoimmunity.
Journal: Advances in protein chemistry and structural biology
Published: May 23, 2026
Engineering of antimicrobial peptides by surface display technologies.
Journal: Advances in protein chemistry and structural biology
Published: January 25, 2026
Rational engineering and yeast surface display of Epinecidin-1 peptides reveal antimicrobial activity and selective anticancer effects.
Journal: Molecular biology reports
Published: January 21, 2026
Toward accurate in silico prediction of antigen binding affinities for antibody engineering.
Journal: Advances in protein chemistry and structural biology
Published: September 19, 2025
Deglycosylation of VEGF Produced in Pichia pastoris Reduces its in Vitro Binding and Angiogenic Effect.
Journal: Biotechnology journal
Published: June 03, 2025
Novel anti-VEGF scFv antibodies with superior in vitro and in vivo activities.
Journal: Scientific reports
Published: March 17, 2025
Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris.
Journal: Microbial biotechnology
Published: May 15, 2024
Cell line development and bioreactor process optimization for an atezolizumab biosimilar.
Journal: Biotechnology and applied biochemistry
Published: April 15, 2024
Loss of carbohydrate sulfotransferase 6 function leads to macular corneal dystrophy phenotypes and skeletal defects in zebrafish.
Journal: The FEBS journal
Published: March 25, 2024
Biomarkers of NRF2 signalling: Current status and future challenges.
Journal: Redox biology
Published: February 16, 2024
Engineering of conserved residues near antibody heavy chain complementary determining region 3 (HCDR3) improves both affinity and stability.
Journal: Biochimica et biophysica acta. Proteins and proteomics
Published: December 16, 2022
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris.
Journal: Scientific reports
Published: December 12, 2022
Last Updated: 09/26/2026